Literature DB >> 1289354

Effect of biofilm culture upon the susceptibility of Staphylococcus epidermidis to tobramycin.

I G Duguid1, E Evans, M R Brown, P Gilbert.   

Abstract

Biofilms of Staphylococcus epidermidis were cultured at various specific growth rates, and susceptibilities to tobramycin were compared with those of equivalent plank-tonic populations. In all instances, susceptibility increased significantly with increasing specific growth rate. However, resuspension of the biofilms increased susceptibility, suggesting some involvement of the glycocalyx in reducing antibiotic permeation of the biofilm. Cells that dispersed spontaneously from the biofilms at steady state were particularly susceptible to this agent. Since such cells correspond to newly-divided daughter cells, the relationship between tobramycin susceptibility and the phase in the division cycle was investigated. Susceptibility was enhanced in cultures dividing synchronously shortly before, during and shortly after cell separation. Perfusion of actively-growing S. epidermidis biofilms with tobramycin also demonstrated increased susceptibility with increasing growth rate, but also showed rapid recovery following removal of the agent.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1289354     DOI: 10.1093/jac/30.6.803

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  21 in total

1.  The relative contributions of physical structure and cell density to the antibiotic susceptibility of bacteria in biofilms.

Authors:  Amy E Kirby; Kimberly Garner; Bruce R Levin
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

2.  Comparative antimicrobial susceptibility of biofilm versus planktonic forms of Salmonella enterica strains isolated from children with gastroenteritis.

Authors:  K Papavasileiou; E Papavasileiou; A Tseleni-Kotsovili; S Bersimis; C Nicolaou; A Ioannidis; S Chatzipanagiotou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-07-18       Impact factor: 3.267

3.  A three-dimensional computer model of four hypothetical mechanisms protecting biofilms from antimicrobials.

Authors:  Jason D Chambless; Stephen M Hunt; Philip S Stewart
Journal:  Appl Environ Microbiol       Date:  2006-03       Impact factor: 4.792

4.  Interaction of Streptococcus pneumoniae and Moraxella catarrhalis: investigation of the indirect pathogenic role of beta-lactamase-producing moraxellae by use of a continuous-culture biofilm system.

Authors:  R K Budhani; J K Struthers
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

5.  Adhesion of slime producing Staphylococcus epidermidis strains to PVC and diamond-like carbon/silver/fluorinated coatings.

Authors:  M Katsikogianni; I Spiliopoulou; D P Dowling; Y F Missirlis
Journal:  J Mater Sci Mater Med       Date:  2006-08       Impact factor: 3.896

Review 6.  Mechanisms of Candida biofilm drug resistance.

Authors:  Heather T Taff; Kaitlin F Mitchell; Jessica A Edward; David R Andes
Journal:  Future Microbiol       Date:  2013-10       Impact factor: 3.165

7.  Modification by surface association of antimicrobial susceptibility of bacterial populations.

Authors:  D G Allison; P Gilbert
Journal:  J Ind Microbiol       Date:  1995-10

Review 8.  Staphylococcus epidermidis--the 'accidental' pathogen.

Authors:  Michael Otto
Journal:  Nat Rev Microbiol       Date:  2009-08       Impact factor: 60.633

9.  Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections.

Authors:  John Curtin; Martin Cormican; Gerard Fleming; John Keelehan; Emer Colleran
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

10.  Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents.

Authors:  G S Baillie; L J Douglas
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.